Mycosis and Antifungal Agents
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".
Deadline for manuscript submissions: 30 April 2026 | Viewed by 901
Special Issue Editors
2. VSV-Consulting-LATAM, Pucón, Chile
Interests: microbiology; epidemiology; medical mycology; mycosis
Interests: medical mycology; environmental mycology; molecular biology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Mycoses, fungal infections spanning superficial to life-threatening invasive forms, present a growing global health concern. Key pathogens include pathogenic, dimorphic, and opportunistic yeast and filamentous fungi, with infections exacerbated in immunocompromised individuals. Synthetic and natural extract antifungals agents target essential fungal processes, inhibiting ergosterol synthesis, disrupting cell wall glucan synthesis, and compromising membrane integrity. Antifungal resistance is rising, driven by factors like widespread antifungal use, biofilm formation, and genetic mutations leading to altered drug targets or efflux pumps. This resistance compromises treatment efficacy, necessitates alternative therapies, and underscores the urgent need for improved diagnostics, stewardship programs, and the development of novel antifungals. Surveillance and research efforts are crucial to mitigating the impact of resistant fungal infections.
Dr. Victor Silva
Dr. Patrício Christian Godoy-Martínez
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mycosis
- antifungal agents
- antifungal resistance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
